S-588410 + Placebo
Phase 2UNKNOWN 1 views this week 0 watching💤 Quiet
Interest: 31/100
31
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Non-small- Cell Lung Cancer
Conditions
Non-small- Cell Lung Cancer
Trial Timeline
Mar 1, 2015 → Sep 1, 2021
NCT ID
NCT02410369About S-588410 + Placebo
S-588410 + Placebo is a phase 2 stage product being developed by Shionogi for Non-small- Cell Lung Cancer. The current trial status is unknown. This product is registered under clinical trial identifier NCT02410369. Target conditions include Non-small- Cell Lung Cancer.
What happened to similar drugs?
7 of 20 similar drugs in Non-small- Cell Lung Cancer were approved
Approved (7) Terminated (6) Active (9)
Hype Score Breakdown
Clinical
12
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02410369 | Phase 2 | UNKNOWN |
Competing Products
20 competing products in Non-small- Cell Lung Cancer